Capital Expenditures for IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's current capital expenditures (TTM) is $124.68M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$124.68M
YoY change
-4.8%
5Y CAGR
+3.0%
Peak year (2019)
$155.22M
Cumulative capital expenditures
$2.16B
CapEx history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
CapEx history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $124.68M | -4.8% | ||
| 2024 | $130.92M | -2.0% | ||
| 2023 | $133.63M | -10.2% | ||
| 2022 | $148.84M | +24.5% | ||
| 2021 | $119.55M | +11.1% | ||
| 2020 | $107.63M | -30.7% | ||
| 2019 | $155.22M | +26.3% | ||
| 2018 | $122.94M | +60.3% | ||
| 2017 | $76.70M | +18.4% | ||
| 2016 | $64.79M | -21.9% | ||
| 2015 | $82.92M | +36.6% | ||
| 2014 | $60.70M | -22.8% | ||
| 2013 | $78.64M | +13.9% | ||
| 2012 | $69.05M | -31.1% | ||
| 2011 | $100.22M | +155.0% | ||
| 2010 | $39.30M | -32.1% | ||
| 2009 | $57.84M | -35.7% | ||
| 2008 | $89.97M | +35.8% | ||
| 2007 | $66.24M | -7.2% | ||
| 2006 | $71.36M | +194.9% | ||
| 2005 | $24.20M | -23.7% | ||
| 2004 | $31.70M | +87.6% | ||
| 2003 | $16.90M | +12.0% | ||
| 2002 | $15.09M | -13.2% | ||
| 2001 | $17.38M | +12.0% | ||
| 2000 | $15.52M | +25.2% | ||
| 1999 | $12.40M | -74.2% | ||
| 1998 | $48.10M | +35.5% | ||
| 1997 | $35.50M | +200.8% | ||
| 1996 | $11.80M | -25.8% | ||
| 1995 | $15.90M | +261.4% | ||
| 1994 | $4.40M | +109.5% | ||
| 1993 | $2.10M | -8.7% | ||
| 1992 | $2.30M | -75.5% | ||
| 1991 | $9.40M | — |
CapEx values are taken from IDEXX Laboratories's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
IDEXX Laboratories (IDXX) most recent annual capital expenditures stands at $124.68M (2025) – edged down 4.8% year-over-year.
Over 2020–2025 (5 years), IDEXX Laboratories capital expenditures expanded at a +3.0% compound annual rate, with the latest reading among the more recent periods of the dataset.
Between 2019 and 2025, IDEXX Laboratories capital expenditures declined 19.7%, falling from $155.22M to $124.68M.
The highest annual capital expenditures of $155.22M was reported in 2019. The lowest in the available history was $2.10M in 1993.
Within Healthcare, IDEXX Laboratories (IDXX) ranks 9th among 8 peers we track. The peer median for capital expenditures is $3.87B.
IDEXX Laboratories Capital Expenditures by Year
IDEXX Laboratories Capital Expenditures 2025: $124.68M
IDEXX Laboratories capital expenditures in 2025 was $124.68M, edged down 4.8% below 2024.
IDEXX Laboratories Capital Expenditures 2024: $130.92M
IDEXX Laboratories capital expenditures in 2024 was $130.92M, edged down 2.0% below 2023.
IDEXX Laboratories Capital Expenditures 2023: $133.63M
IDEXX Laboratories capital expenditures in 2023 was $133.63M, declined 10.2% below 2022.
IDEXX Laboratories Capital Expenditures 2022: $148.84M
IDEXX Laboratories capital expenditures in 2022 was $148.84M, grew 24.5% from 2021.
IDEXX Laboratories Capital Expenditures 2021: $119.55M
IDEXX Laboratories capital expenditures in 2021 was $119.55M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — CapEx
Companies in the same sector as IDEXX Laboratories, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's capital expenditures?
- Latest reported capital expenditures for IDEXX Laboratories (IDXX) is $124.68M (period ending December 31, 2025).
How has IDEXX Laboratories capital expenditures changed year-over-year?
- IDEXX Laboratories (IDXX) capital expenditures changed -4.8% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories capital expenditures?
- IDEXX Laboratories (IDXX) capital expenditures compound annual growth rate is +3.0% over the most recent 5 years available.
When did IDEXX Laboratories capital expenditures hit its highest annual value?
- IDEXX Laboratories capital expenditures reached its highest annual value of $155.22M in 2019.
What was IDEXX Laboratories capital expenditures in 2024?
- IDEXX Laboratories (IDXX) capital expenditures in 2024 was $130.92M.
What was IDEXX Laboratories capital expenditures in 2025?
- IDEXX Laboratories (IDXX) capital expenditures in 2025 was $124.68M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.